Published in J Med Genet on June 01, 1979
Localisation of male determining factors in man: a thorough review of structural anomalies of the Y chromosome. J Med Genet (1981) 1.58
Recurrence risks for neural tube defects in a genetic counseling clinic population. J Med Genet (1981) 1.14
Amniocentesis in the West Midlands: report on 1000 births. J Med Genet (1980) 0.79
Paul Polani and the development of medical genetics. Hum Genet (2007) 0.75
The development of clinical genetics. J Med Genet (1981) 0.75
Alpha-fetoprotein in the antenatal diagnosis of anencephaly and spina bifida. Lancet (1972) 5.04
Prenatal diagnosis of genetic disease in Canada: report of a collaborative study. Can Med Assoc J (1976) 2.07
European experience with prenatal diagnosis of congenital disease: a survey of 6121 cases. Cytogenet Cell Genet (1976) 1.89
Genetic counseling for the older pregnant woman: new data and questions. N Engl J Med (1978) 1.66
Letter: Prospective data on risk of Down syndrome in relation to maternal age. Lancet (1976) 1.57
Should the indications for prenatal chromosome analysis be changed? Br Med J (1977) 1.45
Chromosome abnormalities and maternal age. Lancet (1976) 1.42
Alpha-feto-protein during development and in disease. J Med Genet (1975) 1.22
Editorial: Risk of amniocentesis for prenatal diagnosis. N Engl J Med (1975) 1.22
Tetraploidy in cells cultured from amniotic fluid. Lancet (1970) 1.21
A rapid method for assay of branched-chain keto acid decarboxylation in cultured cells and its application to prenatal diagnosis of maple syrup urine disease. Clin Chim Acta (1978) 1.03
Prenatal diagnosis of galactosaemia. Br Med J (1974) 0.99
Fluorimetric assay for prenatal detection of Hurler and Scheie homozygotes or heterozygotes. Lancet (1978) 0.98
Early antenatal diagnosis of spina bifida in a twin fetus by ultrasonic examination and alpha-fetoprotein estimation. Br Med J (1976) 0.95
Planning an amniocentesis service for Down syndrome. Lancet (1979) 0.92
Chromosome anomalies, mosaicism and dermatoglyphic asymmetry. Ann Hum Genet (1969) 0.87
Prenatal diagnosis of a neural tube defect: Meckel syndrome. J Med Genet (1975) 0.87
Prenatal diagnosis of genetic disorders. J Med Genet (1976) 0.87
Fibroblast phosphodiesterase deficiency in Niemann-Pick disease. Biochem Biophys Res Commun (1977) 0.85
Prenatal diagnosis of xeroderma pigmentosum. Report of the first successful case. Lancet (1974) 0.83
An unexpected high frequency of trisomic fetuses in 229 pregnancies monitored for advanced maternal age. Hum Genet (1977) 0.82
Dark-brown amniotic fluid. Lancet (1977) 0.81
Amniotic cell 4-methylumbelliferyl-alpha-glucosidase activity for prenatal diagnosis of Pompe's disease. J Med Genet (1976) 0.81
Prenatal recognition of 4p- syndrome. J Med Genet (1977) 0.81
Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet (1980) 10.23
Cost analysis of early discharge after hip fracture. BMJ (1993) 6.64
Genetic clinic. A follow-up. Lancet (1971) 6.06
Is travel prophylaxis worth while? Economic appraisal of prophylactic measures against malaria, hepatitis A, and typhoid in travellers. BMJ (1994) 4.58
Views of managed care--a survey of students, residents, faculty, and deans at medical schools in the United States. N Engl J Med (1999) 4.21
Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet (1983) 4.02
Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature. BMJ (2004) 3.86
Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis (1989) 3.86
Investigating onset, cessation, relapse, and recovery: why you should, and how you can, use discrete-time survival analysis to examine event occurrence. J Consult Clin Psychol (1993) 3.77
Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch Dis Child (1981) 3.45
Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol Cell (2000) 3.42
Use of personal medical records for research purposes. BMJ (1994) 3.29
Double-strand breaks stimulate alternative mechanisms of recombination repair. J Mol Biol (1989) 3.23
Fetal loss, gravidity, and pregnancy order. Early Hum Dev (1978) 3.06
Cerebral palsy epidemiology: where are we now and where are we going? Dev Med Child Neurol (1992) 2.96
Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. Proc Natl Acad Sci U S A (2004) 2.88
Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol (1994) 2.73
The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect (2001) 2.69
Apparent prevention of neural tube defects by periconceptional vitamin supplementation. 1981. Int J Epidemiol (2011) 2.68
The design and analysis of longitudinal studies of development and psychopathology in context: statistical models and methodological recommendations. Dev Psychopathol (1998) 2.33
The risk of recurrence after two children with central-nervous-system malformations. Lancet (1967) 2.28
Revised estimates of the maternal age specific live birth prevalence of Down's syndrome. J Med Screen (2002) 2.27
Unanswered questions on neural tube defects. Br Med J (Clin Res Ed) (1987) 2.27
The chemical composition of the lipopolyacarideof Pseudomonas aeruginosa. Biochem J (1969) 2.26
Paradoxical bronchoconstriction in asthmatic patients after salmeterol by metered dose inhaler. BMJ (1992) 2.25
Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet (1981) 2.22
Analysis of national register of Down's syndrome in England and Wales: trends in prenatal diagnosis, 1989-91. BMJ (1993) 2.21
Binding properties of newly identified Xenopus proteins containing dsRNA-binding motifs. Curr Biol (1994) 2.15
Hepatitis and death following vaccination with 17D-204 yellow fever vaccine. Lancet (2001) 2.09
Results of first year (1989) of a national register of Down's syndrome in England and Wales. BMJ (1991) 2.07
National Confidential Enquiry into counselling for genetic disorders by non-geneticists: general recommendations and specific standards for improving care. Br J Obstet Gynaecol (1999) 2.06
Socioeconomic inequalities in risk of congenital anomaly. Arch Dis Child (2000) 2.06
Sex-linked Microphthalmia and Mental Deficiency. Br Med J (1937) 2.05
Interleukin 4 is localized to and released by human mast cells. J Exp Med (1992) 2.00
Factors affecting the incidence of non-metrical skeletal variants. J Anat (1975) 1.97
Screening infants for hearing loss. Arch Dis Child (1989) 1.94
National trends in the certified causes of perinatal mortality, 1968 to 1978. Br J Obstet Gynaecol (1980) 1.89
Tuberculosis screening of new entrants; how can it be made more effective? J Public Health Med (2000) 1.88
The natural history of Niemann-Pick disease type C in the UK. J Inherit Metab Dis (2006) 1.87
Prevention of pyelonephritis by immunization with P-fimbriae. J Urol (1984) 1.85
A unifying explanation of primary generalized seizures through nonlinear brain modeling and bifurcation analysis. Cereb Cortex (2005) 1.83
Progressive cardiomyopathic lentiginosis. Q J Med (1972) 1.83
The study of infectious intestinal disease in England: risk factors for cases of infectious intestinal disease with Campylobacter jejuni infection. Epidemiol Infect (2001) 1.81
Segregation of genetic markers in families with chromosome polymorphisms and structural rearrangements involving chromosome 1. Ann Hum Genet (1974) 1.81
Retrospective analysis of 318 cases of uterine sarcoma. Eur J Cancer (1991) 1.78
Cerebral palsy and severe educational subnormality in low-birthweight children: a comparison of births in 1951-53 and 1970-73. Lancet (1982) 1.77
The development of performance and cost indicators for preschool immunisation. Arch Dis Child (1986) 1.77
Perinatal mortality rates. Br J Hosp Med (1978) 1.74
The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. J Antimicrob Chemother (2007) 1.72
Outcome of pregnancy among women in anaesthetic practice. Lancet (1977) 1.72
Epidemiology of intracranial meningioma. Cancer (1993) 1.70
Maternal serum-alpha-fetoprotein levels and prenatal diagnosis of neural-tube defects. Lancet (1974) 1.69
Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients. Intensive Care Med (2014) 1.68
Comparison of models of maternal age-specific risk for Down syndrome live births. Prenat Diagn (2003) 1.65
Deregulating health: policy lessons from the BSE affair. J R Soc Med (1996) 1.62
Hydronephrosis of pregnancy. Urology (1976) 1.62
A three generation family study of cleft lip with or without cleft palate. J Med Genet (1982) 1.62
Virtual outreach: economic evaluation of joint teleconsultations for patients referred by their general practitioner for a specialist opinion. BMJ (2003) 1.62
Poliomyelitis antibody titres in children and effect of live and inactivated poliovaccine. Lancet (1969) 1.58
Evidence that the Xg locus is inactivated in structurally abnormal X chromosomes. Nature (1970) 1.58
Intergenerational studies of human birthweight from the 1958 birth cohort. 1. Evidence for a multigenerational effect. Br J Obstet Gynaecol (1992) 1.58
In vivo analysis of the Saccharomyces cerevisiae HO nuclease recognition site by site-directed mutagenesis. Mol Cell Biol (1990) 1.58
Expression of HLA antigens, beta 2-microglobulin and enzymes by human amniotic epithelial cells. Nature (1982) 1.57
Early identification of children's special needs: a study in five metropolitan communities. J Pediatr (1987) 1.56
Neural-tube defects and vitamins: the need for a randomized clinical trial. Br J Obstet Gynaecol (1984) 1.56
Validation of influenza and pneumococcal vaccine status in adults based on self-report. Epidemiol Infect (2006) 1.56
A ring D chromosome and anomalous inheritance of haptoglobin type. J Pediatr (1967) 1.54
Evaluation of a sexual abuse prevention program for adults with mental retardation. J Appl Behav Anal (1998) 1.54
Production in vitro of Coccidoides immitis spherules and endospores as a diagnostic aid. Am Rev Respir Dis (1970) 1.53
Prenatal diagnosis in Duchenne muscular dystrophy: Salvage of normal male fetus. Lancet (1978) 1.52
Down's syndrome: screening and antenatal diagnosis regionally in England and Wales 1989-2008. J Med Screen (2010) 1.51
Neurological presentations of hypothyroidism: the importance of slow relaxing reflexes. J R Soc Med (1995) 1.51
Treatment of chronic type B and C hepatitis with interferon alfa: an economic appraisal. Hepatology (1995) 1.51
A form of mucopolysaccharidosis with visceral storage and excessive urinary excretion of chondroitin sulphate. Dev Med Child Neurol (1972) 1.50
The cost of alternative models of care for primary care patients attending accident and emergency departments: a systematic review. J Accid Emerg Med (1998) 1.50
Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. Health Technol Assess (2003) 1.50
Prospects for better perinatal health. Lancet (1980) 1.50
Periconceptional vitamin supplementation and the prevention of neural tube defects in south-east England and Northern Ireland. J Med Genet (1984) 1.48
Medical care use and expenditure among children and youth in the United States: analysis of a national probability sample. Pediatrics (1985) 1.47
Experience with subcutaneous infusion ports in three hundred patients. Surg Gynecol Obstet (1988) 1.47
Parental exposure to x-irradiation and Down's syndrome. Ann Hum Genet (1972) 1.46
Neural tube defects and sex ratios. Am J Med Genet (1987) 1.45
Treatment of unstable fractures of the forearm in children. Is plating of a single bone adequate? J Bone Joint Surg Br (2001) 1.43
Chromosome abnormalities and maternal age. Lancet (1976) 1.42
Extended versus bolus infusion of meropenem and piperacillin: a pharmacokinetic analysis. Minerva Anestesiol (2014) 1.42
Ultraviolet light sensitivity and delayed DNA-chain maturation in Bloom's syndrome fibroblasts. Nature (1977) 1.41
Letter: Screening for neural-tube defects. Lancet (1975) 1.40
The prevention of Down's syndrome. Dev Med Child Neurol (1975) 1.40
Abnormal chromosome complement after normal amniocentesis result. Lancet (1992) 1.40
Testicular temperatures measured by thermistor probe and contact thermography. Fertil Steril (1990) 1.39